Combination of Durvalumab and Chemotherapy to Potentially Convert Unresectable Stage IV Penile Squamous Cell Carcinoma to Resectable Disease: A Case Report

Combination of Durvalumab and Chemotherapy to Potentially Convert Unresectable Stage IV Penile Squamous Cell Carcinoma to Resectable Disease: A Case Report

Penile squamous cell carcinoma is a rare disease entity with poor overall survival in an advanced stage. Few studies have investigated the role of immunotherapy in advanced penile squamous cell carcinoma. Herein, we report a case of stage IV unresectable penile squamous cell carcinoma presenting wit...

Full description

Bibliographic Details
Main Authors: Hao Xiang Chen, Ching-Chan Lin, Che-Hung Lin, Chi-Rei Yang
Format: Article
Language:English
Published: MDPI AG 2022-12-01
Series:Current Oncology
Subjects:
penile cancer
squamous cell carcinoma
durvalumab
immunotherapy
combination
Online Access:https://www.mdpi.com/1718-7729/30/1/26

Similar Items

Similar Items